Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824

被引:64
|
作者
Li, Xiaojin [1 ]
Manjunatha, Ujjini H. [1 ]
Goodwin, Michael B. [1 ]
Knox, John E. [2 ]
Lipinski, Christopher A. [3 ]
Keller, Thomas H. [2 ]
Barry, Clifton E., III [1 ]
Dowd, Cynthia S. [1 ]
机构
[1] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA
[2] Novartis Inst Trop Dis, Singapore 138670, Singapore
[3] Melior Discovery, Waterford, CT 06385 USA
关键词
Mycobacterium tuberculosis; PA-824; solubility; water solubility;
D O I
10.1016/j.bmcl.2008.03.011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nitroimidazoles such as PA-824 and OPC-67683 are currently in clinical development as members of a promising new class of therapeutics for tuberculosis. While the antitubercular activity of these compounds is high, they both suffer from poor water solubility thus complicating development. We determined the single crystal X-ray structure of PA-824 and found a close packing of the nitroimidazoles facilitated by a pseudoaxial conformation of the p-trifluoromethoxybenzyl ether. To attempt to disrupt this tight packing by destabilizing the axial preference of this side chain, we prepared the two diastereomers of the 7-methyl-nitroimidazo-oxazine. Determination of the crystal structure of the 7-(R)-methyl derivative (5, cis) revealed that the benzylic side chain remained pseudoaxial while the 7-(R)-methyl derivative (6, trans) adopted the desired pseudoequatorial conformation. Both derivatives displayed similar activities against Mycobacterium tuberculosis, but neither showed improved aqueous solubility, suggesting that inherent lattice stability is not likely to be a major factor in limiting solubility. Conformational analysis revealed that all three compounds have similar energetically accessible conformations in solution. Additionally, these results suggest that the nitroreductase that initially recognizes PA-824 is somewhat insensitive to substitutions at the 7-position. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2256 / 2262
页数:7
相关论文
共 50 条
  • [1] Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Thompson, Andrew M.
    Blaser, Adrian
    Anderson, Robert F.
    Shinde, Sujata S.
    Franzblau, Scott G.
    Ma, Zhenkun
    Denny, William A.
    Palmer, Brian D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (03) : 637 - 645
  • [2] Synthesis and Structure-Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Kmentova, Iveta
    Sutherland, Hamish S.
    Palmer, Brian D.
    Blaser, Adrian
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    Thompson, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (23) : 8421 - 8439
  • [3] Synthesis and Structure-Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Thompson, Andrew M.
    Sutherland, Hamish S.
    Palmer, Brian D.
    Kmentova, Iveta
    Blaser, Adrian
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (19) : 6563 - 6585
  • [4] Synthesis and Structure-Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Palmer, Brian D.
    Thompson, Andrew M.
    Sutherland, Hamish S.
    Blaser, Adrian
    Kmentova, Iveta
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) : 282 - 294
  • [5] Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution
    Anderson, Robert F.
    Shinde, Sujata S.
    Maroz, Andrej
    Boyd, Maruta
    Palmer, Brian D.
    Denny, William A.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (11) : 1973 - 1980
  • [6] QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824)
    Masand, Vijay H.
    Jawarkar, Rahul D.
    Mahajan, Devidas T.
    Ben Hadda, Taibi
    Sheikh, Javed
    Patil, Komalsingh N.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2624 - 2629
  • [7] Synthesis and Structure-Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-midazo[2,1-b][1,3]oxazine (PA-824)
    Palmer, Brian D.
    Sutherland, Hamish S.
    Blaser, Adrian
    Kmentova, Ineta
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Denny, William A.
    Thompson, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (07) : 3036 - 3059
  • [8] QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824)
    Vijay H. Masand
    Rahul D. Jawarkar
    Devidas T. Mahajan
    Taibi Ben Hadda
    Javed Sheikh
    Komalsingh N. Patil
    Medicinal Chemistry Research, 2012, 21 : 2624 - 2629
  • [9] Structure-Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    Blaser, Adrian
    Palmer, Brian D.
    Sutherland, Hamish S.
    Kmentova, Iveta
    Franzblau, Scott G.
    Wan, Baojie
    Wang, Yuehong
    Ma, Zhenkun
    Thompson, Andrew M.
    Denny, William A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 312 - 326
  • [10] Structure-Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824).
    Cherian, Joseph
    Choi, Inhee
    Nayyar, Arnit
    Manjunatha, Ujjini H.
    Mukherjee, Tathagata
    Lee, Yong Sok
    Boshoff, Helena I.
    Singh, Ramandeep
    Ha, Young Hwan
    Goodwin, Michael
    Lakshminarayana, Suresh B.
    Niyomrattanakit, Pornwaratt
    Jiricek, Jan
    Rayindran, Sindhu
    Dick, Thomas
    Keller, Thomas H.
    Dartois, Veronique
    Barry, Clifton E., III
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (16) : 5639 - 5659